Evidence map›Paper›PMID 35026232›Full record

ArticleMetabolism: clinical and experimental2022

Editorial: Obesity, metabolic phenotypes and COVID-19.

Despina Sanoudou, Michael A Hill, Matthew J Belanger, Kevin Arao, Christos S Mantzoros

Abstract readEditorial
In one paragraph

Article in Metabolism: clinical and experimental, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Repurposing Metformin for Vascular Disease.Current medicinal chemistry · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Despina Sanoudou4th Department of Internal Medicine, Clinical Genomics and Pharmacogenomics Unit, 'Attikon' Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Michael A HillDalton Cardiovascular Research Center and Department of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, 65211, MO, USA. Electronic address: hillmi@missouri.edu.
Matthew J BelangerNortheast Medical Group, Yale New Haven Health, New Haven, CT, USA.
Kevin AraoDepartment of Medicine, Boston VA Healthcare System and Boston University School of Medicine, Boston, MA 02115, USA.
Christos S MantzorosDepartment of Medicine, Boston VA Healthcare System and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adipose TissueAge FactorsComorbidityCOVID-19HumansMetabolic DiseasesMortalityObesityPandemicsPatient AcuityPhenotypePrognosisRespiratory SystemCOVID-19NAFLDObesityObesity phenotypesOutcomesSARS-CoV-2Treatment

Identifiers

PMID35026232
PMCPMC8743503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.